Charles Schwab Investment Management Inc Rezolute, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Rezolute, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 203,581 shares of RZLT stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
203,581
Previous 22,757
794.59%
Holding current value
$1.9 Million
Previous $65,000
1295.38%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RZLT
# of Institutions
100Shares Held
59.6MCall Options Held
713KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$131 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$37.6 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$33.3 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$28.4 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$28.3 Million11.22% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $363M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...